Ramipril 10mg capsules

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Ramipril

Доступна с:

Wockhardt UK Ltd

код АТС:

C09AA05

ИНН (Международная Имя):

Ramipril

дозировка:

10mg

Фармацевтическая форма:

Oral capsule

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 02050501; GTIN: 5012727912219

тонкая брошюра

PACKAGE LEAFLET: INFORMATION FOR THE USER
RAMIPRIL 1.25MG, 2.5MG, 5MG AND 10MG CAPSULES
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
WHAT RAMIPRIL CAPSULES ARE AND WHAT THEY ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE RAMIPRIL CAPSULES
3.
HOW TO TAKE RAMIPRIL CAPSULES
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE RAMIPRIL CAPSULES
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT RAMIPRIL CAPSULES ARE AND WHAT THEY ARE USED FOR
Ramipril capsules contain a medicine called ramipril. This belongs to
a group of medicines called ACE
inhibitors (Angiotensin Converting Enzyme Inhibitors).
RAMIPRIL CAPSULES WORK BY:

decreasing your body’s production of substances that could raise
your blood pressure

making your blood vessels relax and widen

making it easier for your heart to pump blood around your body.
RAMIPRIL CAPSULES CAN BE USED:

to treat high blood pressure (hypertension)

to reduce the risk or delay the worsening of kidney problems (whether
or not you have diabetes)

to treat your heart when it cannot pump enough blood to the rest of
your body (heart failure)

as treatment following heart attack (myocardial infarction)
complicated with heart failure.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE RAMIPRIL CAPSULES
DO NOT TAKE
Ramipril capsules and
TELL
your doctor if:

you are
ALLERGIC
to the active substance or any other ingredients of this medicine
(listed in section 6).

you are allergic to any other ACE inhibitor medicine. Signs of an
allergic reaction

Характеристики продукта

OBJECT 1
RAMIPRIL 10MG CAPSULES, HARD
Summary of Product Characteristics Updated 20-Nov-2018 | Wockhardt UK
Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Ramipril 10mg Capsules, hard
2. Qualitative and quantitative composition
Each capsule, hard contains 10mg ramipril.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Capsule, hard
Purple opaque body and purple opaque cap. The body has “RP 10”
printed in black.
4. Clinical particulars
4.1 Therapeutic indications
• Treatment of hypertension.
• Cardiovascular prevention: reduction of cardiovascular morbidity
and mortality in patients with:
• manifest atherothrombotic cardiovascular disease (history of
coronary heart disease or stroke, or
peripheral vascular disease) or
• diabetes with at least one cardiovascular risk factor (see section
5.1).
• Treatment of renal disease:
• Incipient glomerular diabetic nephropathy as defined by the
presence of microalbuminuria,
• Manifest glo